Bloom Burton Reaffirms “Buy” Rating for Hamilton Thorne Ltd (HTL)

Bloom Burton restated their buy rating on shares of Hamilton Thorne Ltd (CVE:HTL) in a report issued on Wednesday morning.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/28/bloom-burton-reaffirms-buy-rating-for-hamilton-thorne-ltd-htl.html.

About Hamilton Thorne

Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products.

Receive News & Ratings for Hamilton Thorne Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply